Orthofix Medical Inc.OFIXNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +7.61% | +2.67% | +2.27% | +4.59% | +1.97% |
| Gross Profit Growth | +8.94% | -4.42% | +3.55% | +9.97% | -4.58% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +629.65% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +3.93% | +3.87% | +3.89% | +3.32% | +3.36% |
| Weighted Average Shares Diluted Growth | +3.93% | +3.87% | +3.89% | +3.32% | +3.36% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +29.55% | +6.26% | +20.02% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | -57.36% | +15.89% |
| Receivables Growth | +5.16% | +4.97% | +3.35% | +4.78% | +0.77% |
| Inventory Growth | -14.73% | -20.36% | -17.64% | -15.44% | -9.04% |
| Asset Growth | -3.46% | -9.15% | -5.08% | -4.06% | -4.77% |
| Book Value per Share Growth | -19.15% | -22.63% | -19.20% | -18.57% | -13.46% |
| Debt Growth | +53.43% | +40.43% | +49.56% | +49.00% | +27.63% |
| R&D Expense Growth | -0.70% | +1.41% | -11.72% | -14.57% | -18.26% |
| SG&A Expenses Growth | +3.17% | +0.98% | +1.70% | +13.57% | +0.20% |